Essential Partners’s Idexx Laboratories IDXX Stock Holding History

Essential Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.6K	Sell	72 -6	-8%	-$3.29K	0.02%	705
2026 Q2	$41.1K	Sell	78 -373	-83%	-$209K	0.02%	664
2026 Q1	$253K	Sell	451 -7	-2%	-$4.49K	0.09%	254
2025 Q4	$310K	Buy	458 +1	+0.2%	+$681	0.1%	248
2025 Q3	$292K	Buy	457 +6	+1%	+$3.64K	0.1%	251
2025 Q2	$242K	Buy	+451	New	+$216K	0.1%	255

Other funds holding IDXX

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.87B AUM 18.64% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $532M AUM 7.98% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

SBWIC

Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return

Essential Partners's IDXX Position: Q3 2026 in Review

Essential Partners reduced its Idexx Laboratories (IDXX) stake by 7.7% in Q3 2026, selling an estimated $3.29K and leaving 72 shares worth $37.6K. The position accounts for 0.02% of the portfolio, ranked #705.

Essential Partners first reported a position in IDXX in Q2 2025 and has held it in 6 quarters since. The position peaked at $310K in Q4 2025. 157 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Essential Partners held 72 shares of Idexx Laboratories worth $37.6K as of Q3 2026.
Essential Partners sold 6 Idexx Laboratories shares in Q3 2026, an estimated $3.29K.
Idexx Laboratories made up 0.02% of Essential Partners's portfolio in Q3 2026, its #705 holding.
Essential Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 6 quarters since.
Essential Partners's Idexx Laboratories position peaked at $310K in Q4 2025.
157 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.